Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?

by Alyssa M Peckham, Kirk E Evoy, Leslie Ochs, Jordan R Covvey
Published 2018-09-01

A pilot study assessing the addition of a Quit and Win program to pharmacist-led intensive smoking cessation therapy in a predominantly underserved, minority population

by Kirk E. Evoy, Kentya H. Ford, Sabina O. Nduaguba, Amber Taylor, Lindsay Thomas
Published 2019-11-01

Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics

by Kirk E Evoy, Chengwen Teng, Victor G Encarnacion, Brian Frescas, John Hakim, Stephen Saklad, Christopher R Frei
Published 2019-04-01

Receipt of Substance Use Counseling Among Ambulatory Patients Prescribed Opioids in the United States

by Kirk E Evoy, Charles E Leonard, Jordan R Covvey, Leslie Ochs, Alyssa M Peckham, Samantha Soprano, Kelly R Reveles
Published 2020-05-01